Anirban Maitra: Perwez Hussain’s last preprint in Pancreatic Cancer
Anirban Maitra shared a post on X: .
“New preprint from NCI Center for Cancer Research.
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of Pancreatic Cancer.
Perwez Hussain’s last preprint. May he rest in peace.”
Read further.
Source: Anirban Maitra/X
Dr. Anriban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center.
He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023